Using the genetic properties of tumors to classify them more specifically and determine whether they may respond to anti-angiogenic drugs has netted a two-year-old diagnostics firm a $2.5 million round. GeneCentric Diagnostics Inc. is now a commercial-stage company, said former LabCorp exec Dr. Myla Lai-Goldman, who is now CEO of GeneCentric and a venture partner […]
Cancer diagnostics startup GeneCentric Diagnostics, led by former LabCorp (NYSE:LH) executive Dr. Myla Lai-Goldman, has raised $250,000, securities filings show. Besides Lai-Goldman, GeneCentric’s CEO, the filing lists only Dr. Neil Hayes, a professor at the School of Medicine at the University of North Carolina at Chapel Hill. Lai-Goldman could not be reached for comment. But […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.